FDA Drug recall D-0913-2018
Enalapril Maleate Tablets USP
- FDA Drug
- Class III
- terminated
- Published 2018-07-18
On 2018-07-18 the FDA classified a Class III recall of Enalapril Maleate Tablets USP by Wockhardt, citing failed Impurities/Degradation Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0913-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-06-19 |
| Published | 2018-07-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Wockhardt |
| Distribution | US |
Product
Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.
Reason
Failed Impurities/Degradation Specifications
Identifiers
| code_info | Batch# DR10447 (Exp: 4/19); Batch# DR10996 (Exp: 10/19); Batch# DS10201 (Exp: 2/20); and Batch# DR10319 (Exp: 3/20). |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0913-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.